Efficacy of Perioperative Intravenous Dexamethasone on Postoperative Analgesia in Scleral Buckle Surgery: A Randomized Clinical Trial
| Autor: | Matthew N. Henderson, Dimosthenis Mantopoulos, Emilia I. Wheatley, Omar T. Hassan, Jonathan L. Prenner, Howard F. Fine |
|---|---|
| Rok vydání: | 2023 |
| Zdroj: | Ophthalmic Surgery, Lasers and Imaging Retina. 54:238-242 |
| ISSN: | 2325-8179 2325-8160 |
| Popis: | Background and Objective: Postoperative pain is frequently reported following scleral buckle (SB) surgery. This study assessed the efficacy of perioperative dexamethasone on postoperative pain and opioid use following SB. Materials and Methods: Forty-five patients with rhegmatogenous retinal detachments undergoing SB or SB and pars plana vitrectomy were randomly assigned to either standard care of postoperative oral acetaminophen and oxycodone/acetaminophen as needed or standard care plus 8 mg single-dose peri-operative intravenous dexamethasone. A questionnaire was administered on postoperative days 0, 1, and 7 to determine visual analog scale 0 to 10 pain score and number of opioid tablets consumed. Results: Mean visual analog scale score and opioid use were significantly lower in the dexamethasone group on postoperative day 0 compared with control (2.76 ± 1.96 vs 5.64 ± 3.40, P = 0.002; 0.41 ± 0.92 vs 1.34 ± 1.43, P = 0.016). The dexamethasone group also demonstrated significantly lower total opioid use (0.97 ± 1.88 vs 3.69 ± 5.32, P = 0.047). No significant differences in pain score or opioid use were observed on days 1 or 7 ( P = 0.078; P = 0.311; P = 0.326; P = 0.334). Conclusion: Single-dose intravenous dexamethasone following SB can significantly reduce postoperative pain and opioid use. [ Ophthalmic Surg Lasers Imaging Retina 2023;54:238–242.] |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|